Hydrocephalus is a complex condition that affects people differently. That’s why we need you to join HAPPIER, our #hydrocephalus patient registry. Your collective answers help scientists know where to direct their studies. Join today! hydroassoc.org/happier/

Happy to see this work from my research experience at Adel Malek MD PhD's lab being published Journal of Neurosurgery! Check it out! CV Section UTHSC Neurosurgery Tufts Neurosurgery thejns.org/view/journals/…

Grateful to all my colleagues and friends for making this first step possible CereVasc ENERI - Dr. Pedro Lylyk Tufts Neurosurgery Tufts Medical Center First-in-human endovascular treatment of hydrocephalus with a miniature biomimetic transdural shunt jnis.bmj.com/content/early/…

Just Published bit.ly/3lAuyJo & just in ⌛️ for BRAIN Conference. The 1⃣ & ONLY Prof. Lylyk from the fabulous @ENERI_BSAS presenting the cutting edge E-Shunt Adel Malek MD PhD CereVasc Hydrocephalus Assoc. Hydrocephalus Society BSNR The Society of Radiologists in Training ESMINT Society PAIRS Neuro MEA SVIN

The eShunt System, co-invented at #TuftsMC by Neurosurgeon-in-Chief Dr. Carl Heilman & Chief of Neurovascular Surgery Dr. Adel Malek MD PhD is being developed by CereVasc as the first-ever minimally-invasive treatment for communicating hydrocephalus. bit.ly/3oCcUXL

Very glad to be part of this amazing project!

Do you remember our seventh Annual Meeting in Carlsbad, California? 🌊 You can look through photos from past meetings using our Flickr: flickr.com/photos/1979529… Make sure to register for our 20th Annual Meeting July 21-August 4! ➡️pulse.ly/219uxv9ax1

Cerebral veins: a new frontier in Neuro-IR. sciencedirect.com/science/articl… Thanh Nguyen 🇺🇦 Ferdinand Matthew Amans Eytan Raz Uta Hanning alice Waleed Brinjikji Adel Malek MD PhD Thomas Oxley @BDouraied Journal of Neuroradiology

After all those words, I’m at a loss for words. All I can say is thank you to everyone who has inspired and supported me on this path. #2023CNS #IMAGINE #INNOVATE #INSPIRE

Saw my first e-shunt today with Amanda Baker, MD!! Thanks Charles Matouk Yale School of Medicine CereVasc Amazing technology!

Do your patients experience shuffling feet, cognitive impairment, or incontinence? These symptoms may be normal pressure #hydrocephalus and may prequalify your patients for the STRIDE #clinicaltrial—evaluating the #endovascular eShunt® system. Learn more: STRIDEclinicaltrial.com

.CereVasc has reported initial results from its pilot U.S. FDA-approved IDE clinical study of the eShunt system in the treatment of elderly patients with normal-pressure hydrocephalus charles matouk Charles Matouk neuronewsinternational.com/cerevasc-annou…

Team Montefiore Neurointerventional Surgery enrolled another patient in the @cerevasc pilot trial for the E-shunt, an endovascular treatment for NPH 🧠💦 🙏🏻🙏🏻🙏🏻 @circleowillis Montefiore Radiology MMC/AECOM Neurosurg Montefiore-Einstein Neurology Montefiore Health System

New study shows endovascular thrombectomy (EVT) is safe and effective for acute ischemic stroke patients with pre-existing disability—a group often excluded from trials -- with good odds of returning to baseline at 90 days post-EVT. bit.ly/4iXA18x #Stroke

#STROKE: In a secondary analysis of the PACIFIC-STROKE trial, the presence of hemorrhagic infarction was not associated with worse functional outcomes. Pooja Khatri Eric_Smith_VCI Professor Hanne Christensen Gian Marco De Marchis, MD MSc Antony Chen Ashkan Shoamanesh #AHAJournals ahajrnls.org/42lj2Yf

Congrats to the amazing team at CereVasc on FDA Breakthrough Device Designation for the #eShunt in pediatric patients over 12 years of age with communicating #hydrocephalus—a big step toward less invasive care for children. 🔗 [prnewswire.com/news-releases/…] #neurosurgery #FDA

x.com/i/article/1919…

🚨 Study Approved in Canada! STRIDE trial is launching to study the eShunt System — an endovascular alternative to VP shunts for normal pressure hydrocephalus (NPH). 👥 Now enrolling potential candidates 📩 [email protected] RADIS lab Neurovascular Center @ St. Michael's Hospital St. Michael's Hospital Foundation

Health Canada has authorized STRIDE trial for NPH treatment with the minimally invasive CereVasc eShunt® System—now enrolling in 🇨🇦🇺🇸🇦🇷. We’re proud to advance care in neuroscience. Learn more 👉 nphstridestudy.com #CereVasc #eShunt #NPH #STRIDETrial #NeuroInnovation